How to Get Compounded Tirzepatide Online: Step by Step
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded tirzepatide is not the same as brand-name products such as Zepbound or Mounjaro and may differ in formulation, purity, and potency.
You have decided you want to try tirzepatide, and now you are trying to figure out how to actually get it online without getting scammed or breaking any rules. The honest answer is straightforward: you get compounded tirzepatide the same way you get any prescription medication, through a licensed provider who decides it is appropriate for you. Here is how that should work step by step, who may qualify, what drives the cost, and how to tell a legitimate source from one to avoid.
Can you buy compounded tirzepatide online?
You cannot legitimately buy tirzepatide online without a prescription. Tirzepatide is a prescription-only medication, and that does not change because the product is compounded or because you are ordering through a website instead of a pharmacy counter.
What you can do is get a prescription online through a legitimate telehealth program. At most telehealth programs, you complete an intake, a licensed provider reviews your health history, and if the provider decides tirzepatide is clinically appropriate, a prescription is written and sent to a licensed compounding pharmacy. That pharmacy prepares the medication and, at most programs, ships it to you.
The distinction matters. Any site offering to sell you tirzepatide with “no prescription needed,” no health questions, and no provider involved is not operating legitimately. A real evaluation is not a hurdle to get around. It is how a provider catches contraindications, reviews your other medications, and decides whether this medication is appropriate for you specifically.
How to get compounded tirzepatide: the steps
Here is how the process should work at most telehealth programs, from the moment you start to the day the medication arrives.
Step 1: Health history
At most telehealth programs, you fill out an online form covering your health history, current medications, and weight management goals. Be thorough and honest, since this is the information the provider uses to decide whether tirzepatide is appropriate for you.
Step 2: Provider review
A licensed provider reviews your intake, evaluates your history and any contraindications, and decides whether compounded tirzepatide is clinically appropriate. The provider may ask follow-up questions or request lab work, and may decide it is not right for you.
Step 3: Pharmacy preparation
If the provider prescribes it, a state-licensed compounding pharmacy prepares the medication. Ask which pharmacy the program uses and whether supplies for self-injection are included.
Step 4: Delivery and follow-up
The medication usually arrives by mail. A proper program includes follow-up with a licensed provider while you take it. Ask whether follow-up visits and any coaching are included or cost extra.
The point of telehealth is that this happens without a waiting room or a trip across town. It does not mean skipping the medical evaluation. The provider review is the part that makes it legitimate.
What you need to qualify
A licensed provider decides based on your health history, and programs set their own criteria. There is no guaranteed approval, and no program can honestly promise one. Here is the general framework providers work within.
BMI criteria. Many programs use criteria similar to the brand-name label. Zepbound is approved, along with a reduced-calorie diet and increased physical activity, for adults with obesity, or adults with overweight and at least one weight-related condition. In the main trial that supported that approval, enrolled adults had a BMI of 30 or higher, or a BMI of 27 to under 30 with at least one weight-related condition such as high blood pressure, abnormal cholesterol, obstructive sleep apnea, or heart disease[5].
Your health history. The provider should review your current medications, existing conditions, and any contraindications to GLP-1 medication. Tirzepatide should not be used by people with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2[5]. Some other conditions and medication combinations make tirzepatide a poor fit, which is exactly what the review is designed to catch.
A provider may decide it is not appropriate. Even if your BMI meets a program’s threshold, a provider may decide tirzepatide is not clinically appropriate for your specific situation. That is a feature of a real evaluation, not a flaw.
If you want a fuller picture before you start, the GLP-1 eligibility guide walks through what providers look at and how to prepare for an intake.
What compounded tirzepatide costs
One of the most confusing parts of shopping online is the price spread. Some programs advertise a low monthly number, then bill lab work, provider visits, or a membership separately, so the real cost is higher than the headline. Others fold more into one fee. Many charge more as the dose increases.
Transformation Health does not sell medication or set prices. Prices vary by program and dose. When you compare programs, compare the total cost: the medication at your likely dose, dose increases, provider visits, labs, shipping, membership fees, and cancellation terms.
Ask each program one direct question: does the monthly price include the medication, the lab work, and ongoing provider care, at my starting dose and at higher doses? If a program will not answer that clearly, keep looking. For a deeper breakdown, see compounded tirzepatide cost.
Brand-name tirzepatide generally costs more than compounded tirzepatide when paid out of pocket, although manufacturer self-pay programs and insurance coverage can change what you pay. That difference reflects a different production model, not clinical equivalence. Compounded tirzepatide is not FDA-approved and is not the same product as brand-name tirzepatide.
Transformation Health does not accept payment from providers. How we make money.
Injectable only
One thing to set straight before you start: as of October 2026, FDA-approved tirzepatide (Zepbound and Mounjaro) comes only as an injection[5][6]. There is no FDA-approved oral tirzepatide. If a site is advertising “oral tirzepatide” or tirzepatide pills, that product is compounded, is not FDA-approved, and has not been reviewed by the FDA. Ask what it is and which pharmacy prepares it before going further.
Tirzepatide is injected under the skin once weekly and is designed for self-administration at home[5]. The prescriber and pharmacy should give you clear instructions on how to measure and give your dose.
If you would rather not inject, you are not out of options. Semaglutide, a different GLP-1 medication, is available as an FDA-approved daily tablet, and some programs also offer compounded oral semaglutide, which is not FDA-approved. A licensed provider can help you weigh which approach, if any, fits your preferences and health history. If oral is your priority, start with how to get compounded semaglutide.
Getting it from a legitimate source
Not every online seller is legitimate, and the difference is worth knowing before you hand over a payment. A legitimate program shares a few traits.
A prescription is required. Every order is tied to a prescription written by a licensed provider after a real evaluation. No exceptions, no “no prescription needed” shortcuts.
A licensed US pharmacy prepares the medication. Compounded tirzepatide should come from a US-based compounding pharmacy that holds an active license from its state board of pharmacy, or from an outsourcing facility registered with the FDA, which you can check on FDA’s list of registered outsourcing facilities[4]. Some pharmacies also hold voluntary accreditation, such as PCAB accreditation, now administered by ACHC. Be wary of anything shipped from overseas or from a source that will not tell you where it is made.
Labs and monitoring. Ask whether the program requires lab work and how a licensed provider follows up during treatment. A program willing to ship tirzepatide with no health review and no follow-up is cutting corners that matter for your safety.
Transparency, not pressure. A legitimate program explains what is included, what compounded means, and what the medication does and does not do. It does not lean on countdown timers or scarcity threats, and it does not make guaranteed-results claims.
For more on checking a source, see how to choose a safe compounding pharmacy, and the difference between 503A and 503B pharmacies explains why the type of pharmacy matters for how compounded medications are prepared and dispensed.
State requirements
Telehealth rules are not the same everywhere. Some states have rules that affect how a provider can evaluate you and prescribe through telehealth, and some programs require a live video visit before prescribing in certain states. If you are asked to schedule one, it is a normal requirement, not a problem with your application.
Ask the program how it handles your state before you pay, and whether the provider is licensed in the state where you live. A provider may also request a video visit when they feel it is warranted. To see how the online prescription process works end to end, read getting a GLP-1 prescription online.
We're relaunching soon
We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.
Get StartedImportant disclosures
Compounded tirzepatide is not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality[1], and compounded tirzepatide differs from brand-name tirzepatide, which went through FDA review. Compounded tirzepatide contains tirzepatide, but you cannot assume it will produce the same results as Zepbound or Mounjaro; formulation, purity, and potency may differ.
Regulatory status can change. On December 19, 2024, FDA determined that the tirzepatide injection shortage was resolved, and the enforcement discretion periods for shortage-based compounding ended in 2025 (for state-licensed 503A pharmacies after a federal court ruling on March 5, 2025, and for 503B outsourcing facilities on March 19, 2025)[2]. As of October 2026, FDA’s drug shortage database lists the tirzepatide injection shortage as resolved[3]. FDA has posted later updates to its compounding policy, most recently dated April 1, 2026; check the FDA page for the current statement[2]. Availability cannot be guaranteed.
Individual results vary, and weight loss is not guaranteed. How much weight a person loses depends on many factors, including starting weight, age, metabolism, adherence, diet, exercise, sleep, stress, and overall health. A prescription is always required, and a licensed provider decides whether one is appropriate.
Tirzepatide has risks as well as benefits. On the Zepbound label, the most common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection site reactions, fatigue, hypersensitivity reactions, burping, hair loss, and gastroesophageal reflux, and the label carries a boxed warning about thyroid C-cell tumors[5]. Label information describes the brand-name product.
Citations
[1] U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” Content current as of 09/16/2025. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers (Accessed 2026-10-16.)
[2] U.S. Food and Drug Administration. “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” Content current as of 04/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize (Accessed 2026-10-16.)
[3] U.S. Food and Drug Administration. “FDA Drug Shortages: Tirzepatide Injection.” Status: Resolved. Accessed 2026-10-16. https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Tirzepatide%20Injection&st=r
[4] U.S. Food and Drug Administration. “Registered Outsourcing Facilities.” https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities (Accessed 2026-10-16.)
[5] U.S. Food and Drug Administration. ZEPBOUND (tirzepatide) injection, prescribing information. Revised 08/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s041correctedlbl.pdf
[6] U.S. Food and Drug Administration. MOUNJARO (tirzepatide) injection, prescribing information. Revised 04/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215866Orig1s052lbl.pdf
Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Transformation Health is an independent GLP-1 guide. It does not provide medical care, prescribe, compound, or sell medication. A licensed provider decides whether a prescription is appropriate. Compounded tirzepatide is not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality. Compounded tirzepatide is not the same as brand-name products such as Zepbound or Mounjaro and may differ in formulation, purity, and potency. Results vary. Availability of compounded tirzepatide depends on FDA policy and applicable state and federal pharmacy compounding laws, which may change. Zepbound and Mounjaro are trademarks of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by Eli Lilly and Company. Transformation Health does not accept payment from providers. How we make money.